Discover Oncology (Sep 2024)

KIF18B: an important role in signaling pathways and a potential resistant target in tumor development

  • Shicheng Chen,
  • Bo Yu,
  • Guo TU DU,
  • Tian Yu Huang,
  • Neng Zhang,
  • Ni Fu

DOI
https://doi.org/10.1007/s12672-024-01330-4
Journal volume & issue
Vol. 15, no. 1
pp. 1 – 11

Abstract

Read online

Abstract KIF18B is a key member of the kinesin-8 family, involved in regulating various physiological processes such as microtubule length, spindle assembly, and chromosome alignment. This article briefly introduces the structure and physiological functions of KIF18B, examines its role in malignant tumors, and the associated carcinogenic signaling pathways such as PI3K/AKT, Wnt/β-catenin, and mTOR pathways. Research indicates that the upregulation of KIF18B enhances tumor malignancy and resistance to radiotherapy and chemotherapy. KIF18B could become a new target for anticancer drugs, offering significant potential for the treatment of malignant tumors and reducing chemotherapy resistance.

Keywords